Benzinga Novo Nordisk's Newly Approved Weight Loss Pill Shows Record Prescription Data
U.K. drug regulator approves higher Wegovy dose as Novo Nordisk seeks U.S. and EU clearance. Trial data showed up to 21% average weight loss in adults with obesity. read more